TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12047481

Group type: EXPERIMENTAL
Intervention: Cremophor EL (up to 5000 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 10433447

Group type: EXPERIMENTAL
Intervention: 300 mg allopurinol orally on admission and a further 300 mg for another 5 days
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard management for thumb replantation
Number of subjects: 98
Study: 8549148

Group type: EXPERIMENTAL
Intervention: Balsam of Peru and spices (active substances)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 1703602

Group type: EXPERIMENTAL
Intervention: Cromakalim (1 mg) single dose
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cromakalim (1 mg) multiple doses
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cromakalim (1 mg) added to atenolol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cromakalim (1 mg)
Number of subjects: 18
Study: 30898471

Group type: EXPERIMENTAL
Intervention: Single strain (Lactobacillus acidophilus boucardii)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Multispecies probiotics
Number of subjects: 90
Study: 30200893

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MCT)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 618

Group type: COMPARATOR
Intervention: Both MCT and HIIT
Number of subjects: 618

Group type: COMPARATOR
Intervention: Gender comparison
Number of subjects: 618
Study: 26261902

Group type: EXPERIMENTAL
Intervention: Insulin deficiency (fasting C–peptide ≤ 0.15 nmol/l)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: GAD antibodies
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Presence of IAA or baseline insulin use
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: IA2 antibodies
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: ZnT8 antibodies
Number of subjects: 430
Study: 24568798

Group type: EXPERIMENTAL
Intervention: Eyes-closed training program
Number of subjects: 18

Group type: COMPARATOR
Intervention: Eyes open control group
Number of subjects: 18
Study: 23451443

Group type: EXPERIMENTAL
Intervention: Mobile-bearing prosthesis
Number of subjects: 200

Group type: COMPARATOR
Intervention: Fixed-bearing prosthesis
Number of subjects: 200
Study: 20437580

Group type: EXPERIMENTAL
Intervention: B-cell depletion with rituximab
Number of subjects: 0
Study: 17418384

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray, 110 microg once daily
Number of subjects: 299
Study: 16360055

Group type: EXPERIMENTAL
Intervention: CRT-ICD upgrade
Number of subjects: 18
Study: 12003381

Group type: EXPERIMENTAL
Intervention: Cyanoacrylate glue injection
Number of subjects: 37

Group type: COMPARATOR
Intervention: Alcohol injection
Number of subjects: 37
Study: 9856136

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfates 4&6 (CS 4&6) at a dose of 800 mg/d
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 8544412

Group type: EXPERIMENTAL
Intervention: Erythrocyte oxalate flux rate in stone formers
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Renal fractional clearance of oxalate in stone formers
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Correlation between erythrocyte oxalate flux rate and renal fractional clearance of oxalate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Erythrocyte oxalate flux rate in controls
Number of subjects: 20

Group type: COMPARATOR
Intervention: Renal fractional clearance of oxalate in controls
Number of subjects: 20
Study: 2216496

Group type: EXPERIMENTAL
Intervention: Prostacyclin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 420136

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control (unsupplemented)
Number of subjects: 244
Study: 31045465

Group type: EXPERIMENTAL
Intervention: Curcuminoids 4 g/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 27682324

Group type: EXPERIMENTAL
Intervention: Cohort 1993–2000
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Cohort 1997–2004
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Cohort 2000–2006
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Men and women
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Young-old adults (aged 60–74)
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Rural areas
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Transferring
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Bathing
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Toileting
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Dressing
Number of subjects: 3074

Group type: EXPERIMENTAL
Intervention: Feeding
Number of subjects: 3074
Study: 25853236

Group type: EXPERIMENTAL
Intervention: Nebivolol-Valsartan combination (20/320 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nebivolol (20 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Valsartan (320 mg)
Number of subjects: 30
Study: 23419343

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral morphine sulphate
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.05 mg/kg oral midazolam (active placebo)
Number of subjects: 60
Study: 21290145

Group type: EXPERIMENTAL
Intervention: Graded exercise testing (GXT) in CHF patients
Number of subjects: 15

Group type: COMPARATOR
Intervention: Graded exercise testing (GXT) in healthy subjects (HS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Graded exercise testing (GXT)
Number of subjects: 15
Study: 18641099

Group type: EXPERIMENTAL
Intervention: High-resolution CT scan findings in symptomatic SSc patients
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: High-resolution CT scan findings in lcSSc patients
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: High-resolution CT scan findings in dcSSc patients
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Correlation of PF extent with pulmonary function tests
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Correlation of pGGO with BAL fluid
Number of subjects: 162
Study: 15942260

Group type: EXPERIMENTAL
Intervention: Pulse-alone trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prepulse-pulse trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prepulse inhibition
Number of subjects: 0
Study: 12582782

Group type: EXPERIMENTAL
Intervention: Betahistine dihydrochloride (16 mg twice per day for 3 months)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 10484854

Group type: EXPERIMENTAL
Intervention: Rotterdam Symptom Checklist (RSCL) at week 1
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Rotterdam Symptom Checklist (RSCL) at week 2
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Rotterdam Symptom Checklist (RSCL) at week 3
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Comparison of RSCL scores between weeks 1 and 3
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Comparison of RSCL scores between weeks 1 and 2
Number of subjects: 52
Study: 8607394

Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 97

Group type: COMPARATOR
Intervention: Propafenone
Number of subjects: 97
Study: 2006246

Group type: EXPERIMENTAL
Intervention: Indomethacin (150 mg PO)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7020609

Group type: EXPERIMENTAL
Intervention: 14-valent pneumococcal polysaccharide vaccine
Number of subjects: 871

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 871
Study: 30506109

Group type: EXPERIMENTAL
Intervention: Early replacement (ER) group received FXIII concentrate the day after randomization.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group received no FXIII concentrate within 2 weeks.
Number of subjects: 50
Study: 28797305

Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy (VL) using cMac, dBlade, and King Vision
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy (VL)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy (VL) with hyperangulated blade geometries
Number of subjects: 22
Study: 26324089

Group type: EXPERIMENTAL
Intervention: Liraglutide (GLP-1RA)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Glimepiride (SU)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both treatments (Glimepiride and Liraglutide)
Number of subjects: 16
Study: 23151017

Group type: EXPERIMENTAL
Intervention: Glucose intolerance prevalence in girls (4.2%) vs boys (3.2%)
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Adolescent age group
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Waist circumference
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Acanthosis nigricans
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Family history of diabetes
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: HOMA-IR
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: Abdominal obesity in girls
Number of subjects: 1519
Study: 21873490

Group type: EXPERIMENTAL
Intervention: Serum FGF23 levels
Number of subjects: 659
Study: 18294116

Group type: EXPERIMENTAL
Intervention: Active treatment with nitrendipine, enalapril, and/or hydrochlorothiazide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active treatment with perindopril and indapamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Candesartan or hydrochlorothiazide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorthalidone, atenolol, or reserpine
Number of subjects: 0
Study: 16735187

Group type: EXPERIMENTAL
Intervention: Muscle functional MRI (mfMRI)
Number of subjects: 7
Study: 15293527

Group type: EXPERIMENTAL
Intervention: Manidipine (10-20 mg/day)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Enalapril (10-20 mg/day)
Number of subjects: 136
Study: 11167479

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 60
Study: 9432100

Group type: EXPERIMENTAL
Intervention: Boxing training session in the laboratory (BOXL)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Boxing training session in a boxing studio (BOXS)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Incremental running test on the treadmill
Number of subjects: 8
Study: 8430919

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Procaterol
Number of subjects: 14
Study: 3319637

Group type: EXPERIMENTAL
Intervention: Nicardipine 90 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propranolol 240 mg/day
Number of subjects: 30
Study: 30053856

Group type: EXPERIMENTAL
Intervention: Higher vegetable intake (mean 324.6 ± 196.1 g/day)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Higher vegetable variety score (VVS)
Number of subjects: 187
Study: 27245928

Group type: EXPERIMENTAL
Intervention: Water aerobics session (45 minutes at 70%-75% of maximum heart rate)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Water aerobics session
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 24509968

Group type: EXPERIMENTAL
Intervention: Adapalene-benzoyl peroxide topical gel
Number of subjects: 3855

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 3855
Study: 22882692

Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccine
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Non-adjuvanted vaccine
Number of subjects: 78

Group type: COMPARATOR
Intervention: Non-adjuvanted vaccine (healthy controls)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccine (GMT)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Non-adjuvanted vaccine (GMT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Non-adjuvanted vaccine (healthy controls, GMT)
Number of subjects: 78
Study: 20360753

Group type: EXPERIMENTAL
Intervention: Intensive support for implementation of electronic monitoring in 32 experimental pharmacies
Number of subjects: 57

Group type: COMPARATOR
Intervention: Minimal implementation support in 25 control pharmacies
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Experimental group (intensive support)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (minimal support)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 57
Study: 18180628

Group type: EXPERIMENTAL
Intervention: Hydrocodone/acetaminophen (25 mg/2500 mg/d)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Tramadol (200 mg/d)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Hydrocodone/acetaminophen
Number of subjects: 118

Group type: COMPARATOR
Intervention: Tramadol
Number of subjects: 118
Study: 15998652

Group type: EXPERIMENTAL
Intervention: Higher calorie-TPN regimen (40 kcal/kg/day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lower calorie-TPN regimen (30 kcal/kg/day)
Number of subjects: 10
Study: 12972172

Group type: EXPERIMENTAL
Intervention: LSG 1200 mg/day
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: LSG 1500 mg/day
Number of subjects: 264

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study: 11093596

Group type: EXPERIMENTAL
Intervention: Experimental diet high in unsaturated fats, low in saturated fats with hypoallergenic foods
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control well-balanced diet
Number of subjects: 50
Study: 8827124

Group type: EXPERIMENTAL
Intervention: Theatre production
Number of subjects: 77

Group type: COMPARATOR
Intervention: Standard health education seminar
Number of subjects: 77
Study: 8499043

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3945915

Group type: EXPERIMENTAL
Intervention: Thermoradiotherapy (heating tumor to 42-43.5 degrees C using electromagnetic waves at 915 MHz, total ionizing radiation dose of 40 Gy)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (radiation therapy only)
Number of subjects: 48
Study: 29566582

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei SD1-milk
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard-milk (control)
Number of subjects: 124
Study: 26859853

Group type: EXPERIMENTAL
Intervention: Real-time feedback + Traditional feedback (RTF + TF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional feedback (TF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 24261644

Group type: EXPERIMENTAL
Intervention: Intravenous haloperidol 1 mg/q8h
Number of subjects: 2145

Group type: EXPERIMENTAL
Intervention: Intravenous haloperidol 2 mg/q8h
Number of subjects: 2145

Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 2145
Study: 21463024

Group type: EXPERIMENTAL
Intervention: Nap group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Wake group
Number of subjects: 32
Study: 19345451

Group type: EXPERIMENTAL
Intervention: Tryptophan-rich hydrolyzed protein (HP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard casein protein (CP)
Number of subjects: 0
Study: 16786252

Group type: EXPERIMENTAL
Intervention: Computerized proprioception facilitation exercise (CPFE)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Closed kinetic chain exercise (CKCE)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 81
Study: 14981006

Group type: EXPERIMENTAL
Intervention: BQ‐123 (ETA) alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: BQ‐123 (ETA) in combination with BQ‐788 (ETB)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: BQ‐788 (ETB) alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 11233584

Group type: EXPERIMENTAL
Intervention: Lottery participation offered upon return of the questionnaire
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group (no lottery participation)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Lottery participation
Number of subjects: 1000
Study: 9766765

Group type: EXPERIMENTAL
Intervention: Pindolol (5 mg t.i.d.) plus paroxetine (20 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo plus paroxetine (20 mg/day)
Number of subjects: 100
Study: 8142123

Group type: EXPERIMENTAL
Intervention: Radiotherapy alone or radiotherapy combined with surgery and/or chemotherapy
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Intraarterial chemotherapy
Number of subjects: 130
Study: 3133924

Group type: EXPERIMENTAL
Intervention: 50% medium chain triglyceride/50% long chain triglyceride lipid emulsion
Number of subjects: 51

Group type: COMPARATOR
Intervention: 100% long chain triglyceride emulsion
Number of subjects: 51

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 51
Study: 31592513

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-alcohol (0.5%/70%)
Number of subjects: 3665

Group type: COMPARATOR
Intervention: Iodine-alcohol (1%/70%)
Number of subjects: 3665
Study: 29198192

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle cluster (high water and F&V consumption, high PA z scores)
Number of subjects: 5387

Group type: EXPERIMENTAL
Intervention: Unhealthy lifestyle cluster (high soft drinks and screen time z scores, low water, F&V and PA z scores)
Number of subjects: 5387

Group type: COMPARATOR
Intervention: Parental education levels
Number of subjects: 5387
Study: 26253800

Group type: EXPERIMENTAL
Intervention: Buffered 4% lidocaine with 1:100,000 epinephrine buffered with 0.18 mL 8.4% sodium bicarbonate
Number of subjects: 88

Group type: COMPARATOR
Intervention: Nonbuffered 4% lidocaine with 1:100,000 epinephrine
Number of subjects: 88
Study: 22833593

Group type: EXPERIMENTAL
Intervention: Normal down-stroke pattern
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fast down-stroke pattern
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Very fast down-stroke pattern
Number of subjects: 12
Study: 22018299

Group type: EXPERIMENTAL
Intervention: NT‐proBNP-guided care
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard of care (SOC) management
Number of subjects: 151
Study: 18292398

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE); n = 9
Number of subjects: 21

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU); n = 12
Number of subjects: 21
Study: 22360024

Group type: EXPERIMENTAL
Intervention: PRECEDE educational model
Number of subjects: 72
Study: 15995091

Group type: EXPERIMENTAL
Intervention: True TENS
Number of subjects: 74

Group type: COMPARATOR
Intervention: Sham TENS
Number of subjects: 74
Study: 11791098

Group type: EXPERIMENTAL
Intervention: Cold-adapted influenza virus vaccine (CAIV-T) administered by intranasal spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold-adapted influenza virus vaccine (CAIV-T)
Number of subjects: 0
Study: 9579177

Group type: EXPERIMENTAL
Intervention: STIR sequences
Number of subjects: 23

Group type: COMPARATOR
Intervention: SPIR sequences
Number of subjects: 23
Study: 8736266

Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/kg i.v.) alone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/kg i.v.) combined with arginine (0.5 g/kg i.v.)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fasting (3 or 4 days)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 17
Study: 2523226

Group type: EXPERIMENTAL
Intervention: Doxacurium chloride 62.5 micrograms kg‐1 (2.5 x ED95)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Doxacurium chloride 37.5 micrograms kg‐1 (1.5 x ED95)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Edrophonium 1 mg kg‐1
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Neostigmine 50 micrograms kg‐1
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Doxacurium chloride
Number of subjects: 27
Study: 361333

Group type: EXPERIMENTAL
Intervention: Oral oxprenolol 80 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral propranolol 80 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30165858

Group type: COMPARATOR
Intervention: 6 repetition maximum (RM)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 15 repetition maximum (RM)
Number of subjects: 15
Study: 26825017

Group type: EXPERIMENTAL
Intervention: 0.9% normal saline at a dose of 1.5mlkg ‐1 h ‐1 for 12h before surgery
Number of subjects: 328

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 328
Study: 24183068

Group type: EXPERIMENTAL
Intervention: Patient education intervention with audio CD containing information, relaxation, and positive imagery
Number of subjects: 84

Group type: COMPARATOR
Intervention: Regularly treated control
Number of subjects: 84
Study: 22027496

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention for six months
Number of subjects: 0
Study: 20070744

Group type: EXPERIMENTAL
Intervention: Implant placed in extraction socket
Number of subjects: 0
Study: 18162832

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus (LGG) therapy for 4 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 21
Study: 15698707

Group type: EXPERIMENTAL
Intervention: Balance assessments during quiet standing (feet together eyes open, feet together eyes closed, single limb stance eyes open)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Data normalized for height
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Single limb stance trials
Number of subjects: 97
Study: 12681877

Group type: EXPERIMENTAL
Intervention: 100 mg of doxycycline orally twice a day for 7 days
Number of subjects: 800

Group type: COMPARATOR
Intervention: 100 mg of doxycycline orally twice a day for 3 days followed by an oral placebo twice daily for the last 4 days
Number of subjects: 800
Study: 10389286

Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg) every day for six months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Premarin (0.625 mg) every day plus Provera (5 mg) from day 1 to day 12 every month for six months
Number of subjects: 40